SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback